These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3226595)

  • 41. [Estrogen and progesterone receptors in cancer of the female breast: correlation with the age of the patients, fertility status, tumor stage and grading].
    Bracali G; De Magistris A; Olivieri D; Loli MG; Bracali M; Caracino AM; Marinucci R
    Pathologica; 1986; 78(1054):179-94. PubMed ID: 3822562
    [No Abstract]   [Full Text] [Related]  

  • 42. [Immunohistochemical detection of nuclear estrogen receptors with monoclonal antibodies in different types of breast cancer].
    Stegner HE; Jonat W; Maass H
    Pathologe; 1986 May; 7(3):156-63. PubMed ID: 3012503
    [No Abstract]   [Full Text] [Related]  

  • 43. [Value of detection of hormone receptors by biochemical and immunochemical methods in therapeutic decision for breast cancer].
    Goussard J
    Bull Cancer; 1996 Dec; 83(12):1031-6. PubMed ID: 9116370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward the use of monoclonal antibodies in the analysis of tumor progression and cellular heterogeneity of human breast cancer.
    Nilsson K
    Acta Chir Scand Suppl; 1984; 519():15-8. PubMed ID: 6595923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemistry in the evaluation of melanocytic tumors.
    Ruiter DJ; Bröcker EB
    Semin Diagn Pathol; 1993 Feb; 10(1):76-91. PubMed ID: 8506418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigens associated with epithelial ovarian carcinomas.
    Bast RC
    Prog Clin Biol Res; 1989; 288():73-83. PubMed ID: 2785696
    [No Abstract]   [Full Text] [Related]  

  • 47. Improving outcomes for patients with hormone receptor-positive breast cancer: back to the drawing board.
    Ellis MJ
    J Natl Cancer Inst; 2008 Feb; 100(3):159-61. PubMed ID: 18230793
    [No Abstract]   [Full Text] [Related]  

  • 48. Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?
    Arnould L; Coudert B; Fumoleau P
    J Clin Oncol; 2009 Jun; 27(16):2733; author reply 2734-5. PubMed ID: 19380432
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pure colloid carcinoma of the breast: anatomoclinical study of seven cases].
    Chtourou I; Makni SK; Bahri I; Abbes K; Sellami A; Fakhfakh I; Gouiaa N; Ayadi L; Frikha M; Daoud J; Boudawara TS
    Cancer Radiother; 2009 Jan; 13(1):37-41. PubMed ID: 18703371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Steroid hormone receptor status and other immunohistochemical prognostic markers in benign and malignant diseases of the breast].
    Nizze H; al-Thobhani AK; Terpe H
    Zentralbl Chir; 1998; 123 Suppl 5():14-8. PubMed ID: 10063564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunohistochemical detection of bcl-2 and MIB-1/Ki-67 in breast cancer: retrospective analysis of 238 cases].
    Sundlad AS; Ahn C; Battifora H
    Medicina (B Aires); 1996; 56(3):252-8. PubMed ID: 9035481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Estrogen receptors in human breast cancer].
    Ozdağ N
    Turk Hemsire Derg; 1986; 36(3):21-4. PubMed ID: 3649110
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute mixed lineage leukemias.
    Liso V; Specchia G; Pansini N; Colucci A
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():73-5. PubMed ID: 2713564
    [No Abstract]   [Full Text] [Related]  

  • 54. [Determination of cytoplasmic estrogen and progesterone receptors in breast carcinoma: comparison of a histochemical and a radiometric method].
    Wolf D; Forti E; Gion M; Melia M; Dittadi R; Mione R
    Pathologica; 1985; 77(1049):305-9. PubMed ID: 3831881
    [No Abstract]   [Full Text] [Related]  

  • 55. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
    Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
    Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.
    Barnetson RJ; Burnett RA; Downie I; Harper CM; Roberts F
    Am J Clin Pathol; 2006 Jan; 125(1):67-76. PubMed ID: 16482993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The usefulness of steroid hormone receptors in the management of primary and advanced breast cancer.
    McGuire WL
    Eur J Cancer (1965); 1980; Suppl 1():39-43. PubMed ID: 7032943
    [No Abstract]   [Full Text] [Related]  

  • 58. Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site.
    Bayer-Garner IB; Smoller B
    Mod Pathol; 2000 Feb; 13(2):119-22. PubMed ID: 10697267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison of binding patterns of established and new monoclonal antibodies, of antisera and lectins with impulse cytophotometric and morphometric parameters and the hormone receptor status of breast cancer].
    Möller P; Gross C; Feichter G; Mattfeldt T; Kaufmann M
    Verh Dtsch Ges Pathol; 1985; 69():405-8. PubMed ID: 3913203
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytologic diagnosis of low grade endometrial stromal sarcoma by staining for estrogen and progesterone receptors.
    Reich O; Pickel H; Regauer S
    Acta Cytol; 2002; 46(4):790-2. PubMed ID: 12146057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.